Cardiopulmonary effects of a two hour medetomidine infusion and its antagonism by atipamezole in horses and ponies
|
|
- Marcia Black
- 5 years ago
- Views:
Transcription
1 J. vet. Anaesth. Vol. 26(1) (19YY) Cardiopulmonary effects of a two hour medetomidine infusion and its antagonism by atipamezole in horses and ponies R. Bettschart-Wolfensberger, R. W. Bettschart, 0. Vainio, D. Marlin and K. W. Clarke Royal Veterinary College, Hawkshead House, Hawkshead Lane, Hatfield, Hertfordshire AL9 7TA, UK SUMMARY The cardiopulmonary effects of an intravenous (iv) medetomidine injection (5 pg/kg) followed 5 min later by its infusion at 3.5 pg/kg/h for 1 15 rnin were studied in 9 horses and ponies. Five minutes after the end of infusion 60 pg/kg atiparnezole were given. Physiological data during infusion were compared with pre-sedation values. Stroke volume was reduced significantly 5 min after initial medetomidine injection. Cardiac index was reduced significantly and systemic vascular resistance increased significantly for the first 20 min, but returned towards pre-sedation values after this time. Arterial blood pressures were reduced significantly from 30 rnin until the end of the procedure (minimum MAP was f 9.61 mmhg). Mixed venous oxygen tension was reduced significantly during the infusion. Respiratory rate fell and PaCO, - rose significantly from 40 min onward. Other variables showed no significant changes. The horses recovered rapidly after atipamezole was injected. Arterial blood pressures remained significantly lowered, but other cardiovascular variables returned towards pre-sedation values. It is concluded that the infusion of medetomidine at 3.5 pg/kg/h causes minimum cardiopulmonary depression once the effects of an initial 5 pg/kg injection have waned, and so could prove suitable as part of an anaesthetic technique in equidae. INTRODUCTION Alpha,-adrenoceptor agonists are used commonly as sedatives for horses before general anaesthesia. They produce sedation, muscle relaxation and allow smooth induction and recovery from anaesthesia, provide analgesia, reduce the doses of anaesthetic agents required (Short 1992; England and Clarke 1996) and their action can be antagonised (Raekallio et al. 1990). All a2-adrenoceptor agonists produce cardiopulmonary changes in horses, eg a decrease in cardiac output and heart rate and, after iv administration, hypertension. The duration and intensity of these effects depend on the a2-agonist used, its dose and route of administration (Garner et al. 1971; Clarke and Taylor 1986; Wagner et al. 1991; England and Clarke 1996). Propofol has been used as a total iv anaesthetic (TIVA) in horses, in combination with xylazine or detomidine and guaiphenesin or ketamine (Aguiar et al. 1993; Hartsfield et al. 1994; Matthews et al. 1994; Flaherty et al. 1997). However, the drug is expensive, and in larger horses the volumes required are impractical. Medetomidine is the most specific and potent a2-agonist available (Pertovaara 1993) and is effective in reducing the quantity of anaesthetic required. In dogs it reduces the dose of propofol needed for induction and maintenance of general anaesthesia by up to 75% (Hammond and England 1994) and so may be of some use in combination with propofol in horses. Medetomidine possesses a short action and half-life in horses and undergoes rapid clearance (Bettschart- Wolfensberger et al. 1999) so it is a suitable agent for infusion, as changes in plasma levels can be achieved rapidly. A medetomidine infusion, wl:lch provides a constant sedative effect, and steady plasma drug levels for 2 h, has already been established (Bettschart-Wolfensberger el al. 1999). If medetomidine infusion is to be incorporated into an anaesthetic, ie with propofol, knowledge of its cardiopulmonary effects is necessary. The aim of this study was to measure the cardiopulmonary effects of medetomidine given first by rapid iv injection, followed by infusion for 2 h. MATERIALS AND METHODS The present study was undertaken in 9 clinically healthy horses and ponies (one Thoroughbred and 8 Welsh mountain ponies). Mean age (+ sd [range]) was 10.1 f 9.16 (4-24) years, and weight was f ( ) kg. All animals had previously undergone surgery during which the carotid artery was relocated to a subcutaneous position. Animals were fed hay and grass except during the experimental procedure, and allowed free access to water. Catheters used for cardiopulmonary measurements were positioned 2 h before the study. A catheter placed in the jugular vein was used for drug administration. Immediately before each experimental period, horses were left undisturbed and baseline cardiopulmonary variables were recorded. x
2 J. vel. Anaesth. Vol. 260) (1999) Medetomidine (Domitor, Orion-Farmos, Turku, Finland) was injected iv at 5 pg/kg iv. Five minutes later an infusion of medetomidine (3.5 pg/kg/h) was begun, and maintained for 115 min. The solution infused was made by adding 7 pg/kg medetomidine to 360 ml Hartman's solution and giving one drop/s using a commercially available fluid administration set. At the end of infusion atipamezole (Antisedan, Orion-Farmos, Turku, Finland) was given iv at a dose of 60 p&g. Cardiovascular variables and arterial blood gas values were measured using conventional methods. Arterial blood samples were taken from a carotid arterial catheter. The zero level for pressure measurements was set at the manubrium sternae. Cardiac output (CO) was measured using thermal dilution; a volume of 10 m1/100 kg of iced 5% dextrose solution was used. All data were analysed using a haemodynamic computer (Colormon, Kontron Instruments). Analogue information was recorded continuously on videotape, and digital information at 1 rnin intervals on computer. Heart rate (HR), arterial blood pressure, pulmonary arterial and central venous pressure (CVP) were measured continuously before and during medetomidine administration until signs of sedation were no longer evident. Cardiac output and pulmonary capillary wedge pressure were measured before and at 5, 10 and 20 rnin intervals after drug administration and every 20 rnin thereafter throughout infusion. At these times arterial and mixed venous blood samples were taken for blood gas analyses. Blood samples were stored in iced water and analysed within 2 h using a calibrated blood gas machine (ABLS, Radiometer, Copenhagen, Denmark). Cardiopulmonary variables were recorded for 5 rnin after atipamezole injection in those animals that did not become excessively agitated. Data were recorded as mean f sd. Statistical analyses were performed using Statview I1 (Abacus Concepts. California, USA). All data were analysed by ANOVA for repeated measures. When appropriate, Dunnett's post hoc test was used to determine differences from baseline values. RESULTS Data were recorded as mean f sd. Medetomidine. 5 pg/kg iv followed by infusion produced sedation in all horses. The animal's heads were always lowered, but modest stimuli, eg blood collection, occasionally evoked a response, causing the horse to lift its head and/or move its ears. Within 1-2 mill of atipamezole, horses raised their heads, became alert, and some became intolerant of attached physiological equipment. They became calm, but were not resedated when these were disconnected. Four and 5 min after atipamezole administration 2 ponies began shivering, which lasted 6 and 10 min, respectively. Cardiopulmonary data are represented in Tables 1-4. Heart rates fell after medetomidine in.jection and were reduced significantly (P<0.05) at 5 rnin after injection. returning to pre-sedation values in all but one horse. In this horse, heart rate rose from 35 beats/min to a maximum of 61 beats/min 20 rnin after medetomidine and remained elevated until the end of the experiment. Six horses developed cardiac arrhythmias immediately after medetomidine injection; these lasted for up to 7 min. These included first and second degree atrioventricularr block (n=3) and sinus arrhythmia (n=3). Cardiac index (CI) was reduced significantly for the first 20 min, stroke volume (SV) for the first 5 rnin and arterial blood pressure from 30 min onwards until the end of the observation period. Systemic vascular resistance index (SVRI) was increased for the first 20 min. Central venous TABLE 1: Heart rate (HR), cardiac index (Cl), stroke volume (SV), systolic, mean and diastolic arterial blood pressures (SAP, MAP, DAP) and systemic vascular resistance index (SVRI) in 9 ponies and horses given 5 pg/kg medetomidine iv followed after 5 min by 3.5 pg/kg/h medetomidine iv for 115 min followed by 60 pg/kg atipamezole iv after 120 min; mean t sd (range) pre 5min 10min 20min 30min 40min 50min 60min 70min 80min 90min 100min 110min 120min 125min HR 43.3f99 (beatshin) (32-60) 35f7.89t 36 8f t f i8.28 (26-50) (30-47) (3&56) (31-61) (32-59) (33-57) 42.0i t f f i ? f6.92 (34-55) (34-57) (35-56) (35-54) (3553) (3554) (35-55) (36-55) CI 67.7t15.22 (mlikgimin) ( l) sv 0.45fO 27 (Vheart beat) ( ) 41.I f7.78' 46.2f11.55' 49.8f12.30$ 59.2f15.15 ( ) ( ) ( ) ( ) 0.32f0.14t 0 34f fO0.I4 0.38i0.13 ( ) ( ) (O.lW.57) ( ) 63.2M f tl t f17.1T ( ) ( ) ( ) ( )( ) 0.39f f f f f0.15 ( ) (0.2W.64) (0.2I30.77) ( ) ( ) SAP (mmhg) ( ) 168.1f 151.5f 1373f 127.4t f It 8* 13.13' 9.41' ( ) ( ) ( ) ( ) ( ) ( ) 120.9f 120.1t 1201i 121.8f 120.4f 1224t 124.5t 124.6f1 1009' 11 50' 12.69' 13.51' 1264* 13.95' 13.61' 2.91' ( ) ( ) ( ) ( ) ( ) ( ) (10%1451 ( MAP 127.3t (mmhg) 15.3 ( ) 141.3t 129.3f 120.3f 110.4? 106.5t 104.5t * 8.59' 7.05* ( ) ( ) ( ) ( ) ( ) ( ) 105.1i 103.0f 103.8t 103.8f 102.4f 104.9k 107.8i 103.8i 820' 809' 10.00' 10.3* 9.61' 998" 11.70' 12.53' (92-115) (90-113) (90-119) (9&119) (89-114) (89-116) (90-124) (91-124) DAP 109t (mmhg) ( ) 123.1f 115.4f 104.9i 96.4f 92.6t 91.5f * 9.75* 8.19' ( ) ( ) (92-122) ( ) ( ) ( ) 89.6f 89.5f 90.3t 90.0f 89.6f 91.6t 94.6i 89.1f 9.96' 8.02' 9.56' 9.89' 10.23^ 10.16' 12.44$ 12.36' ( ) (77-99) ( ) ( ) ( ) ( ) ( ) ( ) SVRI 1398f 249.6i 202.Of 1788f 131.9f 124.5f 124.li 1149f 123.9t 113.6f (dynes/s/ ' 48.15' 51.70$ cm5kg) ( )( )( I )(I ) ( ) ( ) ( ) ( ) ( ) ( ) pre=previous to drug administration 'Significant difference from pre value (P<O.OI) *Significant difference from pre value (Pc0.05) Y
3 J. vet. Anaesrh. Vol. 26(/) (1999) TABLE 2: Central venous pressure (CVP), mean pulmonary arterial pressure (mpap), pulmonary vascular resistance index (PVRI) and left and right ventricular stroke work index (LVSWI and RVSWI) in 9 ponies and horses given 5 pg/kg medetomidine iv followed after 5 min by 3.5 pg/kg/h medetomidine iv for 115 min followed by 60 pg/kg atipamezole iv after 120 min; mean f sd (range) pre 5 rnin 10 rnin 20 min 40 rnin 60 rnin 80 min 100 rnin 120 min 125 rnin CVP 15.9f f k f k f t k k5.83 (mmhg) (6-23) (9-22) (9-22) 9-23) (9-21) (7-17) (7-20) (7-19) (6-17) (7-27) mpap 28.2k f f k f f f f6.37 (mmhg) (16-36) (23-36) (21-34) (1841) (21-32) (18-36) (1632) (15-33) (17-36) (20-39) PVRI 11.0f k f ? , f k k4.61 idynesis ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) /cm5/kg LVSWI 2.2k f f $ kO.35* k k0.29' (grn/kg/ ( ) ( ) (1.15f2.19) ( = ( ) ( ) ( ) ( ) ( ) ( ) heart beat RVSWI 0.25k f k B fl f k f f f0.04 (gm/kg/ ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) heart beat) TABLE 3: Respiratory rate (RR), blood ph and arterial blood gas values in 8 ponies and one horse given 5 pglkg medetomidine iv followed after 5 rnin by 3.5 pglkglh medetomidine iv for 115 min followed by 60 pglkg atipamezole iv after 120 min; mean f sd (range) pre 5rnin 10min 20rnin 30rnin 40min 50min 60min 70min 80min 90min 100min 110rnin 120rnin 125min RR 25 8f f f t f4 12' 11.8f1.56' 10 Of2.00' 9.8f1.92' 9.4f1.67' 8.8i1.72' 8.8?1 49' 7.8f1.28' 9.5f2.07' (breathdmin) (12-42) (12-32) (10-27) (12-46) (12-44) (10-20) 8-20) (10-14) (8-12) (8-12) (8-12) (6-12) (8-12) (6-10) (8-12) PH 7.42f f tO t f f f f0.01 ( )( )( ) ( ) ( ) ( ) ( ) ( ) ( ) pc0, 5.9f f t $ 6.4rO f0.41$ 6.6i0.26' 6.5t0.18' 6.5f0.43' (kpa) (5.S.7) ( ) (5.M.5) ( ) ( ) ( ) ( ) ( ) ( ) PO, 14.1? rO f1.14* 12.6f fI rO ? rO f0.43 (kpa) ( )( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) HCO, f f il.20' 31.2fl.30' tl 01 * 31.6fl.81' mmolil (26-30) (27-31) (27-31 j (27-31 j (28-32) (30-34) (30-34) (30-33) (28-34) ABE 3.4? i f i fl.09' 6.1 fl.of 6 1?0.93* * 6.4fl.33 mmolil (2-6) (2-5) (2-6) (2-6) (3-6) (5-8) (5-8) (5-7) (4-8) 'Significant difference from pre value (P<O.Ol) *Significant difference from pre value (P<0.05) TABLE 4: Mixed venous blood ph and mixed venous blood gas vallues in 9 ponies and horses given 5 pg/kg medetomidine iv followed after 5 min by 3.5 pg/kg/h medetomidine iv for 115 rnin followed by 60 pg/kg atipamezole iv after 120 min; mean f sd (range) pre 5 min 10 min 20 min 40 min 60 min 80 min 100 min 120 rnin PH 7.39k fl f k B k f0.02 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) PCO, 6.7f k k f t f * (kp4 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) PO2 4.45f k0.51* 3.6t0.44* 3.8f0.36* 3.8f0.46' 3.8f0.38' 3.8k0.29' * 3.8k0.34' (W ( ) ( ) ( ) ( ) ( ) ( ) (26-4.3) (3.24.3) ( ) HCO, f k t1.04* 32.2f1.60t * * mmol/l (27-33) (2&32) (2SG32) (29-32) (27-33) (31-34) 29-34) 31-35) (31-36) ABE 3.8f k k I 6 4.8k f1.13* * 6.2?1.04* 6.6f1.06' mmolll (2-6) (2-6) (3-6) (3-6) (3-7) (4-7) (3-7) (5-8) (5-8) pre=previous to drug administration 'Significant difference from pre value (P<O.Ol) 'Significant difference from pre value (P<O 05)
4 - -.I. vel Anaesth. Vol 26(1/ (1999) pressure, pulmonary arterial pressure and pulmonary vascular resistance index (PVRI) did not change significantly when compared to pre-sedation values. Respiratory rate (RR) was reduced significantly 40 rnin after medetomidine injection and remained depressed until the end of the experiment. This coincided with a significant increase in PCO, which developed 20 min after injection and persisted throughout the second hour of observation. There were no significant changes in PO,. Mixed venous PO, was significantly lower than baseline values after 5 rnin while mixed venous PCO, increased after 120 min. Base excess (BE) and bicarbonate (HCO,) were significantly elevated from 60 rnin after injection until the end of the measurement period. One pony, whose resting respiratory rate had been 16 breaths/min, became tachypnoeic with respiratory rates between 44 and 46 breaths/min 20 and 30 rnin after medetomidine injection. At these time points, all other variables were similar to the mean values of other animals. Six of the 9 animals urinated up to 4 times during the infusion period. DISCUSSION In the current study, 5 pg/kg medetomidine injection followed by its infusion at 3.5 pg/kg/h produced constant sedation, with minimal ataxia. The degree of sedation was similar to that reported previously (Bettschart- Wolfensberger et al. 1999) and appeared comparable with the sedation observed in horses at mean detomidine plasma levels of 19.1 ng/ml (Daunt et a/. 1993). The horses reacted slightly when being approached, although the degree of sedation present would probably have been adequate for standing chemical restraint. Medetomidine reduces the dose of propofol required to produce anaesthetic in a dosedependent manner in dogs (Hammond and England 1994). In horses, medetomidine administration is limited by the degree of ataxia produced (Bryant ef al. 1991). The infusion rate used in the current study was considered to be the greatest that would not cause ataxia Alpha2-adrenoceptor agonists produce similar cardiopulmonary changes in horses (England and Clarke 1996). These include: a fall in heart rate, a reduction in cardiac output and a biphasic change in blood pressure. lnitial hypertension is due to stimulation of peripheral a2- receptors (Docherty and McGrath 1980) and not as compensation for bradycardia (Sarazan et al. 1989; Bryant et al. 1991). Injection of medetomidine 5 or 10 pg/kg produces similar changes in ponies (Bryant et a/. 1991). In the current study, cardiovascular changes began after the initial injection of medetomidine and were similar to those described above. However, within 30 min, when steady state medetomidine plasma levels would have been reached (Bettschart-Wolfensberger et a/. 1999) the values of variables other than blood pressure did not differ significantly from those recorded before treatment. Studies in man suggest that bradycardia following dexmedetomidine (the active enantiomer of medetomidine) depends on plasma levels of the drug (Dyck et al. 1993; Jalonen et al. 1997). Simon el a/. (1989) and Hayashi et a/. (199.5) suggested that decreases in heart rate in dogs are independent of dose and mode of medetomidine administration, but the doses they used were high (20 pg/kg) and it is possible that lower dose rates would cause less bradycardia. In the present study bradyarrythmias were observed in 6 ponies, but these had disappeared within 7 min, possibly because plasma drug levels had fallen below a dysrhythmogenic threshold value. In the current study. the bradycardia observed was less severe, and of shorter duration, than that seen with detomidine infusions which produce similar degrees of sedation (Daunt eta/. 1993). The reason why the heart rate increased, rather than decreased, in one horse is difficult to explain given that variables were similar to those observed in the other animals. The reduction of CI that occurred within 5 min of medetomidine injection was similar to that seen after iv xylazine (1.1 mag, Kerr et al. 1972). In the current study cardiac output was reduced both by a reduction in HR and in SV, but the reduction was short-lived. From 40 rnin onward it did not differ significantly from pre-sedation values and remained stable during infusion. The initial rise in blood pressure encountered in the present study was not statistically significant (probably because of high pre-sedation MAP) but by 30 rnin after starting infusion it had fallen significantly and remained low thereafter. The onset of the hypotensive phase coincided with a fall in SVRI. Similar hypotensive changes have been reported following xylazine, detomidine and romifidine (Clarke el af. 1991; Wagner et a/. 1991). Although hypotension was observed in the present study MAP was stable from 30 rnin onwards and remained within the accepted physiological ranges (Dyson and Pascoe 1990). The transient increase in SVRI which occurred during the first 20 rnin correlates with that seen after other a?- adrenoceptor agonists (Wagner et al. 1991). Daunt et al. (1 993) gave an infusion of detomidine to horses using increasing doses to determine cardiopulmonary side-effects of different plasma levels. At plasma detomidine concentrations which produced degrees of sedation similar to those seen in the current study, MAP was not significantly different from pre-sedation values, but systemic vascular resistance was increased significantly. Increasing dose rates of detomidine causes hypertension that corresponds with further increases in systemic vascular resistance. With the infusion rate used in the present study, it is possible that the plasma level of medetomidine achieved was insufficient to induce vasoconstriction Alpha2-adrenoceptor agonists can cause respiratory depression in horses (Short et al. 1986; Wagner el a/. 1991). After xylazine or detomidine Wagner el a/. ( 1991) reported a transient initial fall in PaO, without a change in PaC0,. probably due to ventilation-perfusion imbalance. However, changes in arterial blood gas tensions have not been significant in all reports (Bryant et al. 1991; Daunt et a/ 1993). In the present study there was a marked reduction in RR in all but one pony, and a small rise in PaCO,. but this may become significant at the end of the infusion. In most animals Pa0, did not change although, in one pony, it fell to
5 J. vel. Anuesth. Vol. X (I/ (1999) a minimum value of 9.2 kpa. Values for PvO, were reduced significantly from pre-sedation values throughout the procedure, the greatest fall corresponding to significant falls in CI. The hyperventilation seen in one pony was similar to that seen during medetomidine infusion (Bettschart- Wolfensberger et al. 1999) and after the rapid injection of other a,-adrenoceptor agonists (Clarke and Geering et al. 1989). The cause is unknown. The cardiopulmonary effects of atipamezole could not be measured accurately for a definite period because the antagonism of sedation caused animals to shake their heads, producing measurement artefacts. The effects of atipamezole on cardiopulmonary function after constant medetomidine infusion remain to be determined. Nevertheless, all horses in the present study showed a prompt recovery after atipamezole administration, and the dose chosen (60 pg/kg) was sufficient to antagonise sedation, without causing stimulation. The dose of atipamezole required to antagonise medetomidine incorporated in a general anaesthetic technique remains to be established. It should be noted that atipamezole will antagonise the analgesic effects of medetomidine (Ewing el al. 1993). Furthermore, its use may be unnecessary as, at the doses used, there is no accumulation of medetomidine (Bettschart-Wolfensberger, et cil. 1999). The present study demonstrated that an iv injection of medetomidine (5 pg/kg) causes similar cardiopulmonary changes to those caused by other a,-adrenoceptor agonists. However, cardiovascular variables improve during the subsequent 2 h infusion of medetomidine at 3.5 pg/kg/h. The present data indicate that medetomidine infusion warrants further investigation as part of a total iv anaesthetic regime in equidae. The availability of a rapid and specific-acting antagonist is an additional advantage. REFERENCES Aguiar, A,. Hussni, C.A., Luna. St. P.. Ca,tro, G.B., Massone, F. and Alvea, A.L.G. ( 1993) Propofol compared with propofol/guaifenesin after detomidine premedication for equine surgery. J. vet. Anuesih. 20, Bettschart-Wolfcnsberger. R., Clarke, K.W., Vainio, O., Shojaee Aliabadi, F. and Demuth, D. (1999) Pharmacokinetics of medetomidine in ponies and elaboration of a medetomidine infusion regime which provides a constant level of scdation. Res. vet. Sci. 67, Bryant, C.E., England, G.C.W. and Clarke, K.W. (1991) Comparison of the sedative effects of medetomidine and xylazine in horses. Vet. Rec. 129, Bryant. C.E., Clarke, K.W. and Thompson, J. (1996) Cardiopulmonary effects of medetornidine in sheep and ponies. Res. vet. Sci. 60, Clarke. K.W. and Taylor, P.M. (1986) Detomidine: A new sedative for horses. Eqirine vet. J. 18, Clarke, K.W., England, G.C.W. and Goossens, L. (1991) Sedative and cardiovascular effects of romifidine alone, and in combination with hutorphanol. in the horse..j. vet. Anuesih. 18, Clarke, K.W. and Gerring, E.L. (1989) Detoniidine as a sedativc and premedicant in the horse ( ) Proc. Am. Ass. equine Prac/. pp Daunt, D.A., Dunlop, C.I.. Chapman, Ph. L., Shafer, St. L., Ruskoaho, H., Vdkkuri, 0.. Hodgson, D.S., Tyler, L.M. and Maze, M. (1993) Cardiopulmonary and behavioral responses to computer-driven infusion of detomidine in standing horses. Am. J. rvi. Res. 54, Docherty, J.R. and McGrath, J.C. (1980) A comparison of pre- and postjunctional potencies of several alpha-adrcnoceptor agonists in the cardiova5cular system and anococcygeus muscle of thc rat. Evidence for two types of postjunctional alpha-adrenoceptor. Nairnvn-Schmipclc.h~.r~t:',s Arch. Pharmucol. 312, Dyck, J.B., Maze, M., Haak, C., Vuorilehto, L. (1903) Thc pharmacokinctics and hemodynamic elfects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human voulnteers. Anesthesiology 78, Dyson, H.D. and Pascoe, P.J. (1990) Influence of preinduction methoxamine, lactated ringer solution, or hypertonic saline solution infusion or postinduction dobulamine infusion on anesthetic-induced hypotension in horses. Am. J. vet. Rex 51, England. G.C.W. and Clarke, K.W. (1996) Alpha? adrcnoccptor ngonists in the horse- a rcview. Br. vet..i. 152, Ewing, K.K.. Mohammed, H.O., Scarlett. J.M. and Short. C1i.E. (1993) Reduction of isollurane anesthetic requircmcnt by medetomidine and its restoration by atipamezole in dogs. Am. J. vet. Res. 54, Flaherty, D., Reid, J., Welsh, E., Monteiro, A.M., Lerche, P. and Nolan, A. (1997) A pharniacodynamic study of propofol or propofol and ketatnine in ponies undergoing surgery. Rex. ve/. Sci. 62, Garner, H.E., Amend, J.F. and Rosborough, J.P. (1971) Effects of Bay Va 1470 on cardiovascular parameters in ponics. Ve/. Med. & sndl Anim. Clin. 66, Hammond, R.A. and England, G.C.W. (1994) Thc cffcct of medetomidine premedication upon propofol induction and infusion anaesthesia in the dog..i. vet. Anaesth. 21, Hartsfield, S.M., Matthews, N.S., Taylor. T.S., Hooper, R.N. and Erickson, S.W. (1994) Detomidine-propofol anesthesia for carotid artery translocation in donkeys. Vet. Sirrg. 23, Hayashi, K., Nishimura, R., Ydmaki, A., Kim, H. Y., Matsunaga, S., Sasaki. N. and Takeuchi, A. (I 995) Cardiopulmonary effects of niedetoniidine. medetomidine-niidazolam and medetornidinc-midazolan~-ati~~iiiie~~~le in dogs. J. vet. med. Sci. 57, Jalonen, J., Hynynen, M., Kuitunen, A,, Hcikkilii. H., Perttilii. J.. Salnienperii, M., Valtonen, M., Aantaa, R. and Kallio, A. (1997) Dcxmcdetornidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology 86, Ken; D. D., Jones, E. W., Huggins, K. and Edwards, W. C. (1972) Sedative and other effects of xylazine given intravenously to horses. Ant. J. re/. Res. 33, Matthews, N. S., Chaffin, N. K., Hartsfield, S. M. and Overhulse. W. A. (1994) Propofol for immobilization of neonatal foals. k/. Swg. 23, 76, Pertovaara, A. ( 1993) Antinociception induced by alpha,-adrcnoceptor agonists. with special emphasis on medetomidine studies. Progr. Neurohiol. 40, Raekallio, M., Vainio. 0. and Karjalainen, J. (1990) The intlucncc of alipamerole on thc cardiovascular effects of detomidine in horscs..j. t'et. Anuesih. 17, Sarazan, R. D., Starkc. W. A., Krause. G. F. and Garner. H. E. (1089) cardiovascular effects of detomidine, a new a,-adrenoccptor agonist in thc conscious pony..i. vet. Pharmncol. Therap: 12, Short, C. E. (1992). Alpha2-ugenls in Animals. Smfation. Antrlgc.sitr urid Aneslhesin. Santa Barbara, CA. U.S.A.: Veterinary Practice Publishing Company. Short, C. E.. Matthews. N., Harvey, R. and Tyner. C. L. (1086) Cardiovascular and pulmonary function studies of a new sedative/analgesic (detomidine/domosedaii~) for use alone in horses or preanesthetic. Actu vet. Scund. 82, Simon, F., Romviry, A. and Mora, S. (1989) Clinical investigations ol medetomidine in dogs. Acia vel. Scund. 85, I6 I Wagner, A. E., Muir, W. W. and Hinchcliff, K. W. (1991) Cardiovascular effects of xylazine and detomidine in horses. Am. J. PI. Res. 52, I2
Reversal of Medetomidine-Ketamine Combination Anesthesia in Rabbits by Atipamezole
Exp. Anim. 53(5), 423 428, 2004 Reversal of Medetomidine-Ketamine Combination Anesthesia in Rabbits by Atipamezole Min Su KIM 1), Seong Mok JEONG 1), Jae Hak PARK 2), Tchi Chou NAM 1) and Kang Moon SEO
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Medeson 1 mg/ml solution for injection for dogs and cats [AT, CY, CZ, DE, EL, ES, HR, IT, LT, LV, PL, PT, RO, SI, SK] Medeson,
More informationDexmedetomidine. Dr.G.K.Kumar,M.D.,D.A., Assistant Professor, Madras medical college,chennai. History
Dexmedetomidine Dr.G.K.Kumar,M.D.,D.A., Assistant Professor, Madras medical college,chennai Dexmedetomidine is the most recently released IV anesthetic. It is a highly selective α 2 -adrenergic agonist
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Dormilan solution for injection for dogs and cats [FR] Dormilan 1 mg/ml solution for injection for dogs and cats [DE, ES,
More informationCardiovascular, respiratory, electrolyte and acid base balance during continuous dexmedetomidine infusion in anesthetized dogs
Veterinary Anaesthesia and Analgesia, 2013, 40, 464 471 doi:10.1111/vaa.12036 RESEARCH PAPER Cardiovascular, respiratory, electrolyte and acid base balance during continuous dexmedetomidine infusion in
More informationSummary of Product Characteristics
Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Domitor 1 solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: Medetomidine hydrochloride (equivalent
More information1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT
PACKAGE LEAFLET FOR: Dormilan solution for injection for dogs and cats [FR] Dormilan 1 mg/ml solution for injection for dogs and cats [DE, PT, UK] Reanest 1 mg/ml solution for injection for dogs and cats
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Narcostart 1 mg/ml solution for injection for cats and dogs (NL, AT, BE, CZ, EL, HU, IS, LU, PL, SK)
SUMMARY OF PRODUCT CHARACTERISTICS Revised: September 2015 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Narcostart 1 mg/ml solution for injection for cats and dogs (NL, AT, BE, CZ, EL, HU, IS, LU, PL, SK)
More informationA New Advancement in Anesthesia. Your clear choice for induction.
A New Advancement in Anesthesia Your clear choice for induction. By Kirby Pasloske When using Alfaxan, patients should be continuously monitored, and facilities for maintenance of a patent airway, artificial
More informationPremedication with alpha-2 agonists procedures for monitoring anaesthetic
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Premedication with alpha-2 agonists procedures for monitoring anaesthetic Author : Lisa Angell, Chris Seymour Categories :
More informationOxygenation in Medetomidine-Sedated Dogs with and without 100% Oxygen Insufflation
J. C. H. Ko, A. B. Weil, T. Kitao, M. E. Payton, and T. Inoue Oxygenation in Medetomidine-Sedated Dogs with and without 100% Oxygen Insufflation Jeff C. H. Ko, DVM, MS, DACVA a Ann B. Weil, DVM, MS, DACVA
More informationDISSOCIATIVE ANESTHESIA
DISSOCIATIVE ANESTHESIA Adarsh Kumar Dissociative anesthesia implies dissociation from the surrounding with only superficial sleep mediated by interruption of neuronal transmission from unconscious to
More informationClinical effects and pharmacokinetic variables of romifidine and the peripheral a 2 -adrenoceptor antagonist MK-467 in horses
Veterinary Anaesthesia and Analgesia, 2016, 43, 599 610 doi:10.1111/vaa.12354 RESEARCH PAPER Clinical effects and pharmacokinetic variables of romifidine and the peripheral a 2 -adrenoceptor antagonist
More informationUSE OF MEDETOMIDINE HYDROCHLORIDE AS SEDATIVE IN CATTLE CALVES
ISSN 1023-1072 Pak. J. Agri., Agril. Engg., Vet. Sci., 2010, 26 (2): 87-99 USE OF MEDETOMIDINE HYDROCHLORIDE AS SEDATIVE IN CATTLE CALVES 11 A. B. Kalhoro, M. Tariq, A. B. Kachiwal, R. Rind, D. H. Kalhoro
More informationDexmedetomidine and its Injectable Anesthetic-Pain Management Combinations
Back to Anesthesia/Pain Management Back to Table of Contents Front Page : Library : ACVC 2009 : Anesthesia/Pain Management : Dexmedetomidine Dexmedetomidine and its Injectable Anesthetic-Pain Management
More informationClinical applicability of dexmedetomidine for sedation, premedication and analgesia in cats 1 / 2007
1 / 2007 Clinical applicability of dexmedetomidine for sedation, premedication and analgesia in cats 1 5 Dexmedetomidine: a new 2-adrenoceptor agonist for modern multimodal anaesthesia in dogs and cats
More informationDay 90 Labelling, PL LABELLING AND PACKAGE LEAFLET
LABELLING AND PACKAGE LEAFLET A. LABELLING PARTICULARS TO APPEAR ON THE OUTER PACKAGE : Carton 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Alvegesic vet. 10 mg/ml Solution for injection for Horses, Dogs
More informationHemodynamic effects of dexmedetomidine in isoflurane-anesthetized cats
Veterinary Anaesthesia and Analgesia, 2011, 38, 555 567 doi:10.1111/j.1467-2995.2011.00663.x RESEARCH PAPER Hemodynamic effects of dexmedetomidine in isoflurane-anesthetized cats Bruno H Pypendop*, Linda
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
Butomidor 10 mg/ml - Solution for injection for horses, dogs and cats SPC_labelling_PIL 22 December 2011 [Version 7.2, 12/2008] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL
More informationA comparison of three combinations of injectable anesthetics in miniature donkeys
Veterinary Anaesthesia and Analgesia, 2002, 29, 36^42 RESEARCH PAPER A comparison of three combinations of injectable anesthetics in miniature donkeys Nora S Matthews DVM, Dip ACVA, Tex S Taylor DVM, Dip
More informationAlfaxan. (alfaxalone 10 mg/ml) Intravenous injectable anesthetic for use in cats and dogs. TECHNICAL NOTES DESCRIPTION INDICATIONS
Alfaxan (alfaxalone 10 mg/ml) Intravenous injectable anesthetic for use in cats and dogs. NADA 141-342, Approved by FDA ALFAXAN (Schedule: C-IV) (alfaxalone 10 mg/ml) Intravenous injectable anesthetic
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Xylacare 2% w/v Solution for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances Qualitative composition
More informationVol. 24, No. 5 May Animal Care Center of Sonoma County Sonoma, California Marcia L. Aubin, DVM, MS*
Vol. 24, No. 5 May 2002 411 CE Article #5 (1.5 contact hours) Refereed Peer Review Comments? Questions? Email: compendium@medimedia.com Web: VetLearn.com Fax: 800-556-3288 KEY FACTS Achieving adequate
More informationOral sedation of horses
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Oral sedation of horses Author : Aimi Duff Categories : Equine, Vets Date : September 28, 2015 Sedation is sometimes necessary
More informationA Clinical Study of Dexmedetomidine under Combined Spinal Epidural Anaesthesia at a Tertiary Care Hospital
Original Research A Clinical Study of Dexmedetomidine under Combined Spinal Epidural Anaesthesia at a Tertiary Care Hospital Kamala GR 1, Leela GR 2 1 Assistant Professor, Department of Anaesthesiology,
More informationPreliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit
Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit R. M. Venn, 1 C. J. Bradshaw, 1 R. Spencer, 2 D. Brealey, 3 E. Caudwell, 3 C. Naughton,
More informationTotal Intravenous Anaesthesia (TIVA) in Veterinary Practice
Total Intravenous Anaesthesia (TIVA) in Veterinary Practice Rukmani Dewangan 1, S. K. Tiwari 2 1, 2 Department of Veterinary Surgery and Radiology, College of Veterinay Science and A.H. Anjora Durg (C.G.),
More informationA study to evaluate buprenorphine at 40 lg kg )1 compared to 20 lg kg )1 as a post-operative analgesic in the dog
Veterinary Anaesthesia and Analgesia, 211, 38, 584 593 doi:1.1111/j.1467-2995.211.656.x RESEARCH PAPER A study to evaluate buprenorphine at 4 lg kg )1 compared to 2 lg kg )1 as a post-operative analgesic
More informationThe Minimum Infusion Rate (MIR) of Propofol for Total Intravenous Anesthesia after Premedication with Xylazine in Horses
FULL PAPER Surgery The Minimum Infusion Rate (MIR) of Propofol for Total Intravenous Anesthesia after Premedication with Xylazine in Horses Kazuomi OKU 1) *, Minoru OHTA 1), Takashi YAMANAKA 1), Yutaka
More informationPain Management in Racing Greyhounds
Pain Management in Racing Greyhounds Pain Pain is a syndrome consisting of multiple organ system responses, and if left untreated will contribute to patient morbidity and mortality. Greyhounds incur a
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 10 Mar 2019 06:52:14 GMT) CTRI Number Last Modified On 29/07/2016 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. Name of the Veterinary Medicinal Product Vetofol 10mg/ml Emulsion for Injection for cats and dogs (AT, CY, EE, FI, DE, EL, LV, PT, ES) Norofol 10mg/ml Emulsion for
More informationBehavioral responses following eight anesthetic induction protocols in horses
Veterinary Anaesthesia and Analgesia, 2002, 29, 207^211 RESEARCH PAPER Behavioral responses following eight anesthetic induction protocols in horses Ann E Wagner DVM, MS, Diplomate ACVP, ACVA, Khursheed
More informationDOI /yydb medetomidine a review of clinical applications J. Curr Opin Anaesthesiol
1573 medetomidine a review of clinical applications J. Curr Opin Anaesthesiol 2008 21 4 457-461. 6 DAHMANI S PARIS A JANNIER V et al. Dexmedetom- 2. α 2 idine increases hippocampal phosphorylated extracellular
More informationThe effect of rnedetornidine premedication upon propofol induction and infusion anaesthesia in the dog
J. vet. Anaesth. Vol. 21 uuly 1994) The effect of rnedetornidine premedication upon propofol induction and infusion anaesthesia in the dog R.A. Hammond and G.C.W. England Department of Large Animal Surgery
More informationCandidate Name: PRACTICAL Exercise Medications & Injections
PRACTICAL Exercise Medications & Injections VERY IMPORTANT Method: In groups - staggered - PLEASE WAIT YOUR TURN / STAND BACK IF ASKED Do bookwork - work out dosages - 1a / 2a / 3a Got to Medications Table
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT NOSEDORM 5 mg/ml Solution for injection for dogs and cats [DE, ES, FR, PT] 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each
More informationWhat dose of methadone should I use?
What dose of methadone should I use? Professor Derek Flaherty BVMS, DVA, DipECVAA, MRCA, MRCVS RCVS and European Specialist in Veterinary Anaesthesia SPC dose rates for Comfortan dogs: 0.5-1.0 mg/kg SC,
More informationThe cardiovascular and respiratory effects of medetomidine and thiopentone anaesthesia in dogs breathing at an altitude of 1486 m
Article Artikel The cardiovascular and respiratory effects of medetomidine and thiopentone anaesthesia in dogs breathing at an altitude of 1486 m K E Joubert a and R Lobetti b ABSTRACT The purpose of this
More informationAnaesthesia and Analgesia of fish
Anaesthesia and Analgesia of fish Dr Stewart Fielder Port Stephens Fisheries Institute Marine fish production and enhancement Plan of talk Who uses anaesthetics for fish Why anaesthetics are used When
More informationT u l a n e U n i v e r s i t y I A C U C Guidelines for Rodent & Rabbit Anesthesia, Analgesia and Tranquilization & Euthanasia Methods
T u l a n e U n i v e r s i t y I A C U C Guidelines for Rodent & Rabbit Anesthesia, Analgesia and Tranquilization & Euthanasia Methods Abbreviations: General Considerations IV = intravenous SC = subcutaneous
More informationAnesthetic regimens for mice, rats and guinea pigs
Comparative Medicine SOP #: 101. 01 Page: 1 of 10 Anesthetic regimens for mice, rats and guinea pigs The intent of the Standard Operating Procedure (SOP) is to describe commonly used methods to anaesthetize
More informationComparison of three anaesthetic protocols in Bennett s wallabies (Macropus rufogriseus)
Veterinary Anaesthesia and Analgesia, 2010, 37, 207 214 doi:10.1111/j.1467-2995.2009.00523.x RESEARCH PAPER Comparison of three anaesthetic protocols in Bennett s wallabies (Macropus rufogriseus) Tim Bouts*,
More informationPreanesthesia in dogs Dog Weight. Sedation/analgesia in dogs Dog Weight. Sedation/analgesia and preanesthesia in cats
Package Insert NADA 141-267, Approved by FDA. (dexmedetomidine hydrochloride) Sterile Injectable Solution 0.5 mg/ml Intramuscular and Intravenous use in Dogs Intramuscular use in Cats Sedative, Analgesic,
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT DEXDOMITOR 0.1 mg/ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: Excipients:
More informationCanine Dosing Chart DEXDOMITOR
Canine Dosing Chart DEXDOMITOR (dexmedetomidine) -.5 mg/ Preanesthesia in dogs Sedation/analgesia in dogs Canine Weight 5 IM 375 IM 375 IV 5 IM lb kg kg kg kg kg 4.4 7 3.4.4 8.. 8.. 4.5 7. 3. 4 8.3.5 5.5
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Anaestamine 100 mg/ml solution for injection Aniketam, 100 mg/ml solution for injection (EE/LT/LV) Aniketam vet., 100 mg/ml
More informationthe same safe, reliable sedation and analgesia as DEXDOMITOR. specifically made for cats that weigh 7 lb or less.
feline dosing chart DEXDOMITOR 0.1 mg/ml (dexmedetomidine) Sedation/analgesia in cats Feline 40 mcg/kg IM lb kg ml 2 4 1 2 4.1 7 2.1 3 0.5 1.0 For higher weight ranges, use DEXDOMITOR (dexmedetomidine),
More informationHealth Products Regulatory Authority
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Ketamidor 100 mg/ml solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: Active substance: Ketamine (as hydrochloride) Excipient:
More informationComparison of anesthesia with a morphine lidocaine ketamine infusion or a morphine lidocaine epidural on time to extubation in dogs
Veterinary Anaesthesia and Analgesia, 2016, 43, 86 90 doi:10.1111/vaa.12273 SHORT COMMUNICATION Comparison of anesthesia with a morphine lidocaine ketamine infusion or a morphine lidocaine epidural on
More informationPakistan Veterinary Journal
RESEARCH ARTICLE Pakistan Veterinary Journal ISSN: 5-88 (PRINT), 74-7764 (ONLINE) Accessible at: www.pvj.com.pk A Comparison of Anesthetic and Cardiorespiratory Effects of Tiletamine-Zolazepam/Xylazine
More informationNon-invasive, mildly to moderately painful, procedures and examinations which require restraint, sedation and analgesia in dogs and cats.
1. NAME OF THE VETERINARY MEDICINAL PRODUCT Sedadex 0.1 mg/ml solution for injection for dogs and cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: Active substance: Dexmedetomidine hydrochloride
More informationThis SOP presents commonly used anesthetic regimes in rabbits.
Comparative Medicine SOP #: 103. 01 Page: 1 of 7 Rabbit Anaesthesia The intent of this Standard Operating Procedure (SOP) is to describe commonly used methods to anesthetize rabbits at Comparative Medicine
More information! The best anaesthesia is the one you have experience with!
WILDLIFE CHEMICAL CAPTURE AND ANAESTHESIA II! C. Walzer! Research Institute of Wildlife Ecology! University of Veterinary Medicine, Vienna, Austria! Wisdom 1! The best anaesthesia is the one you have experience
More informationTiletamine-Zolazepam anesthesia in horses : repeated dose versus continuous infusion
Tiletamine-Zolazepam anesthesia in horses : repeated dose versus continuous infusion M.A. LÔPEZ, J. JIMÉNEZ, M.F. MARTÌN, J.M. USÓN, E.M. PÉREZ and L.J. EZQUERRA* Hospital Clínico Veterinario, Universidad
More informationSummary of Product Characteristics
Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Narketan-10 100 mg/ml Solution for Injection. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active substance
More informationComparison of 3 Total Intravenous Anesthetic Infusion Combinations in Adult Horses
Comparison of 3 Total Intravenous Anesthetic Infusion Combinations in Adult Horses Courtney L. Baetge, DVM Nora S. Matthews, DVM, Dip. ACVA Gwendolyn L. Carroll, DVM, Dip. ACVA Texas A&M University College
More informationOriginal Article Dose-dependent effects of dexmedetomidine during one-lung ventilation in patients undergoing lobectomy
Int J Clin Exp Med 2017;10(3):5216-5221 www.ijcem.com /ISSN:1940-5901/IJCEM0012317 Original Article Dose-dependent effects of dexmedetomidine during one-lung ventilation in patients undergoing lobectomy
More informationStanding sedation with medetomidine and butorphanol in captive African elephants (Loxodonta africana)
Standing sedation with medetomidine and butorphanol in captive African elephants (Loxodonta africana) I. Lüders a,b, B. Tindall c, D. Young d, G. van der Horst a,b, S. Botha e, I. Luther a,b, L. Maree
More informationCepesedan 10 mg/ml, Solution for Injection for Horses and Cattle
1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cepesedan 10 mg/ml, Solution for Injection for Horses and Cattle DE: Cepesedan RP 10 mg/ml, Solution for Injection for Horses and Cattle AT / BE / ES / FR /
More informationCombination of Continuous Intravenous Infusion Using a Mixture of Guaifenesin- Ketamine-Medetomidine and Sevoflurane Anesthesia in Horses
FULL PAPER Surgery Combination of Continuous Intravenous Infusion Using a Mixture of Guaifenesin- Ketamine-Medetomidine and Sevoflurane Anesthesia in Horses Kazuto YAMASHITA, Masato SATOH, Akiko UMIKAWA,
More informationGUIDELINES FOR ANESTHESIA AND FORMULARIES
GUIDELINES FOR ANESTHESIA AND FORMULARIES Anesthesia is the act of rendering the animal senseless to pain or discomfort and is required for surgical and other procedures. Criteria for choosing an anesthetic
More informationAustralian and New Zealand College of Veterinary Scientists. Membership Examination. Veterinary Anaesthesia and Critical Care Paper 1
Australian and New Zealand College of Veterinary Scientists Membership Examination June 2015 Veterinary Anaesthesia and Critical Care Paper 1 Perusal time: Fifteen (15) minutes Time allowed: Two (2) hours
More informationPropofol vs Dexmedetomidine
Propofol vs Dexmedetomidine A highlight of similarities & differences Lama Nazer, PharmD, BCPS Critical Care Clinical Pharmacy Specialist King Hussein Cancer Center Outline Highlight similarities and differences
More informationCorresponding author: V. Dua, Department of Anaesthesia, BJ Wadia Hospital for Children, Parel, Mumbai, India.
Comparative evaluation of dexmedetomidine as a premedication given intranasally vs orally in children between 1 to 8 years of age undergoing minor surgical procedures V. Dua, P. Sawant, P. Bhadlikar Department
More informationEFFECTS OF DIFFERENT COMBINATIONS OF ACEPROMAZINE, DETOMIDINE, XYLAZINE AND KETAMINE ON SERUM CORTISOL LEVEL OF STANDING SEDATED HORSES ABSTRACT
Rashid et al., The Journal of Animal & Plant Sciences, 28(3): 2018, Page: The J. 960-964 Anim. Plant Sci. 28(3):2018 ISSN: 1018-7081 Short Communication EFFECTS OF DIFFERENT COMBINATIONS OF ACEPROMAZINE,
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nerfasin vet. 100 mg/ml, solution for injection for cattle and horses (AT, BE, CZ, DK, EL, FI, FR, HU, IS, LU, NL, NO, PL,
More informationtake pain out of the pet s experience.
take pain out of the pet s experience. The analgesic properties of DEXDOMITOR (dexmedetomidine) give dogs and cats respite from mild or moderate pain associated with a procedure. By reducing discomfort,
More informationAustralian College of Veterinary Scientists Fellowship Examination. Veterinary Anaesthesia and Critical Care Paper 1
Australian College of Veterinary Scientists Fellowship Examination June 2011 Veterinary Anaesthesia and Critical Care Paper 1 Perusal time: Twenty (20) minutes Time allowed: Three (3) hours after perusal
More informationHemodynamic effects of dexmedetomidine-- fentanyl vs. nalbuphine--propofol in plastic surgery
Hemodynamic effects of dexmedetomidine-- fentanyl vs. nalbuphine--propofol in plastic surgery Juan F. De la Mora-González *, José A. Robles-Cervantes 2,4, José M. Mora-Martínez 3, Francisco Barba-Alvarez
More informationSCIENTIFIC COOPERATIONS MEDICAL WORKSHOPS July, 2015, Istanbul - TURKEY
21-22 July, 2015, Istanbul - TURKEY PROSPECTIVE EVALUATION OF CORRELATION OF DEPTH OF DEXMEDETOMIDINE SEDATION AND CLINICAL EFFECTS FOR RECONSTRUCTIVE SURGERIES UNDER REGIONAL ANAESTHESIA Alma Jaunmuktane
More informationP-ISSN: ; E-ISSN: Journal of Veterinary.
Research Article P-ISSN: 2304-3075; E-ISSN: 2305-4360 International Journal of Veterinary Science www.ijvets.com; editor@ijvets.com Effects of Ketamine-Medetomidine and Ketamine-Medetomidine-Morphine Anaesthesia
More informationJeff Baier MS DVM Birds of Prey Foundation Broomfield, CO
Jeff Baier MS DVM Birds of Prey Foundation Broomfield, CO drjeffbaier@gmail.com Squamates Chelonians Snakes Lizards Varanids Monitor Lizards Crocodilians Reptilian adaptations Anaerobic glycolysis Low
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Acecare 2mg/ml Solution for Injection for Dogs and Cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of solution contains
More informationEarn a rebate on pioneering brands you trust.
SPRING INTO SPRING PROMOTION Earn a rebate on pioneering brands you trust. For over 20 years and with your help, Zoetis has changed the veterinary world with the shared vision to provide comfort through
More informationFeline blood transfusions: preliminary considerations
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Feline blood transfusions: preliminary considerations Author : Andrea Harvey Categories : RVNs Date : September 1, 2011 ABSTRACT
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cepedex 0.1 mg/ml solution for injection for dogs and cats. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains:
More informationYamaguchi University. Naotami UEOKA. The United Graduate School of Veterinary Science
Antagonistic effects of atipamezole, flumazenil and 4-aminopyridine on anesthesia and stress-related neurohormonal and metabolic changes induced by medetomidine, midazolam and ketamine in cats The United
More informationSedative and antinociceptive effects of dexmedetomidine and buprenorphine after oral transmucosal or intramuscular administration in cats
Veterinary Anaesthesia and Analgesia, 2014, 41, 90 96 doi:10.1111/vaa.12076 RESEARCH PAPER Sedative and antinociceptive effects of dexmedetomidine and buprenorphine after oral transmucosal or intramuscular
More informationBenefits of total intravenous anaesthesia in dogs and cats
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Benefits of total intravenous anaesthesia in dogs and cats Author : KATHERINE ROBSON Categories : Vets Date : November 17,
More informationCO Oguntoye* & BO Oke
RESEARCH ARTICLE Sokoto Journal of Veterinary Sciences (P-ISSN 1595-093X/ E-ISSN 2315-6201) Oguntoye & Oke /Sokoto Journal of Veterinary Sciences (2014) 12(3): 21-25 http://dx.doi.org/10.4314/sokjvs.v12i3.4
More informationAshraf Darwish, Rehab Sami, Mona Raafat, Rashad Aref and Mohamed Hisham
Dexmedetomidine versus Propofol for Monitored Anesthesia Care In Patients Undergoing Anterior Segment Ophthalmic Surgery Under Peribulbar Medial Canthus Anesthesia Ashraf Darwish, Rehab Sami, Mona Raafat,
More informationUniversity of Bristol - Explore Bristol Research
Taylor, P. M., Hoare, H. R., de Vries, A., Love, E. J., Coumbe, K. M., White, KL., & Murrell, J. C. (216). A multicentre, prospective, randomised, blinded clinical trial to compare some perioperative effects
More informationArticle Artikel. M Bush a*, J P Raath b, L G Phillips c and W Lance d
Article Artikel Immobilisation of impala (Aepyceros melampus) with a ketamine hydrochloride/medetomidine hydrochloride combination, and reversal with atipamezole hydrochloride M Bush a*, J P Raath b, L
More informationSTANDARD OPERATING PROCEDURE #111 RAT ANESTHESIA
STANDARD OPERATING PROCEDURE #111 RAT ANESTHESIA 1. PURPOSE This Standard Operating Procedure (SOP) describes methods for anesthetizing rats. 2. RESPONSIBILITY Principal Investigators (PIs) and their research
More informationSTANDARD OPERATING PROCEDURE #110 MOUSE ANESTHESIA
STANDARD OPERATING PROCEDURE #110 MOUSE ANESTHESIA 1. PURPOSE This Standard Operating Procedure (SOP) describes methods for anesthetizing mice. 2. RESPONSIBILITY Principal Investigators (PIs) and their
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ANESKETIN 100 mg/ml solution for injection for dogs, cats and horses Belgium: NIMATEK 100 mg/ml solution for injection for
More informationAustralian and New Zealand College of Veterinary Scientists. Fellowship Examination. Veterinary Anaesthesia and Critical Care Paper 1
Australian and New Zealand College of Veterinary Scientists Fellowship Examination June 2016 Veterinary Anaesthesia and Critical Care Paper 1 Perusal time: Twenty (20) minutes Time allowed: Three (3) hours
More informationProcedure # IBT IACUC Approval: December 11, 2017
IACUC Procedure: Anesthetics and Analgesics Procedure # IBT-222.04 IACUC Approval: December 11, 2017 Purpose: The purpose is to define the anesthetics and analgesics that may be used in mice and rats.
More informationDepartment of Laboratory Animal Resources. Veterinary Recommendations for Anesthesia and Analgesia
Department of Laboratory Animal Resources Guideline Veterinary Recommendations for Anesthesia and Analgesia A. PRINCIPLES OF ANESTHESIA AND ANALGESIA 1. The proper anesthetic and analgesic agents must
More informationStudy between clonidine and dexmedetomidine in attenuation of pressor response during endotracheal intubation
Original Research Article Study between clonidine and dexmedetomidine in attenuation of pressor response during endotracheal intubation K. Selvarju 1, Kondreddi Narayana Prasad 2*, Ajay Kumar Reddy Bobba
More informationStudy the Effect of Dexmedetomidine on Emergence Agitation after Nasal Surgeries
Original Research Article Study the Effect of Dexmedetomidine on Emergence Agitation after Nasal Surgeries G V Krishna Reddy 1*, S. Kuldeep 2, G. Obulesu 3 1 Assistant Professor, Department of Anaesthesiology,
More information6/10/2015. Multi Purpose Canine (MPC) Restraint and Physical Examination PFN: Terminal Learning Objective. Hours: Instructor:
Multi Purpose Canine (MPC) Restraint and Physical Examination PFN: Hours: Instructor: Slide 1 Slide 2 Terminal Learning Objective Action: Communicate knowledge of Multi Purpose Canine (MPC) restraint and
More informationQuality of MRI pediatric sedation: Comparison between intramuscular and intravenous dexmedetomidine
Egyptian Journal of Anaesthesia (2013) 29, 47 52 Egyptian Society of Anesthesiologists Egyptian Journal of Anaesthesia www.elsevier.com/locate/egja www.sciencedirect.com Research Article Quality of MRI
More informationSAFETY PHARMACOLOGY: CARDIOVASCULAR TELEMETRY. Aileen Milne PhD, Manager, Safety Pharmacology
SAFETY PHARMACOLOGY: CARDIOVASCULAR TELEMETRY Aileen Milne PhD, Manager, Safety Pharmacology SAFETY PHARMACOLOGY SERVICES OVERVIEW Full Range of S7A and S7B studies herg assay Respiratory function plethysmography(rat/mouse)
More informationBritish Journal of Anaesthesia 83 (3): (1999)
British Journal of Anaesthesia 83 (3): 372 80 (1999) CLINICAL INVESTIGATIONS Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions
More informationPharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care ²
British Journal of Anaesthesia 88 (5): 669±75 (2002) Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care ² R. M. Venn 1*, M. D. Karol 2 and R.
More informationA Comparison of the Incidence of Apnoea Following Induction of Anaesthesia with Propofol or Alfaxalone in Dogs
A Comparison of the Incidence of Apnoea Following Induction of Anaesthesia with Propofol or Alfaxalone in Dogs Sarah Elizabeth Bigby ORCID ID: orcid.org/0000-0003-2814-0569 Student ID: 642933 Submitted
More informationDıfferent Doses Of Dexmedetomidine On Controllıng Haemodynamıc Responses To Tracheal Intubatıon
ISPUB.COM The Internet Journal of Anesthesiology Volume 27 Number 2 Dıfferent Doses Of Dexmedetomidine On Controllıng Haemodynamıc Responses To Tracheal Intubatıon A Sa??ro?lu, M Celik, Z Orhon, S Yüzer,
More informationEQUINE ANESTHESIA. Introduction. Standing chemical restraint and preanesthetic agents. Lyon Lee DVM PhD DACVA
EQUINE ANESTHESIA Lyon Lee DVM PhD DACVA Introduction Higher morbidity and mortality associated with general anesthesia (1:100) in comparison to small animals (1:1000) or human (1: 200,000) No change of
More information